Connect with us

Business

Oxford-AstraZeneca vaccine is cheaper than Pfizer’s and Moderna’s and doesn’t require supercold temperature – The Conversation US

There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the…

Published

on

post featured image

The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 and it has several advantages over those of its competitors, Pfizer and Moderna.
On Monday, AstraZeneca released interim analysis of its phase 3 trial data of 23,000 volunteers from the U.K. and Brazil. These results show that the test vaccine is between 70% and 90% effective in stopping COVID-19, depending on the vaccine doses administered. Although less effective than…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending